Hugh C. Leonard

Kingston Upon Thames, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.

How to foster new treatment development in ultra-rare tumours? Joint EMA-EORTC multi-stakeholder workshops on ultra-rare sarcomas as a model for rare cancers.

Journal: Cancer treatment reviews

Published: June 13, 2025

Identifying interventions to optimise advanced kidney care services: scoping review protocol.

Identifying interventions to optimise advanced kidney care services: scoping review protocol.

Journal: BMJ open

Published: March 25, 2025

The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments.

The patient perspective on sirolimus for epithelioid hemangioendothelioma (EHE): results of a community survey highlighting the importance of equitable access to treatments.

Journal: Frontiers in oncology

Published: January 08, 2024

GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression.

GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 03, 2024

The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.

The observational EURACAN prospective clinical registry dedicated to epithelioid hemangioendothelioma: The protocol of an international and collaborative effort on an ultra-rare entity.

Journal: PloS one

Published: December 27, 2023

New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE).

New Molecular Insights, and the Role of Systemic Therapies and Collaboration for Treatment of Epithelioid Hemangioendothelioma (EHE).

Journal: Current treatment options in oncology

Published: February 22, 2023

Manipulation of tissue factor-mediated basal PAR-2 signalling on macrophages determines sensitivity for IFNγ responsiveness and significantly modifies the phenotype of murine DTH.

Manipulation of tissue factor-mediated basal PAR-2 signalling on macrophages determines sensitivity for IFNγ responsiveness and significantly modifies the phenotype of murine DTH.

Journal: Frontiers in immunology

Published: July 21, 2022

Supportive care needs of patients living with an extremely rare and unpredictable cancer: The Epithelioid Haemangioendothelioma patient experience.

Supportive care needs of patients living with an extremely rare and unpredictable cancer: The Epithelioid Haemangioendothelioma patient experience.

Journal: European journal of cancer care

Published: February 27, 2021

Long-term kidney function of patients discharged from hospital after an intensive care admission: observational cohort study.

Long-term kidney function of patients discharged from hospital after an intensive care admission: observational cohort study.

Journal: Scientific reports

Published: January 08, 2021

Regression of Atherosclerosis in ApoE-/- Mice Via Modulation of Monocyte Recruitment and Phenotype, Induced by Weekly Dosing of a Novel "Cytotopic" Anti-Thrombin Without Prolonged Anticoagulation.

Regression of Atherosclerosis in ApoE-/- Mice Via Modulation of Monocyte Recruitment and Phenotype, Induced by Weekly Dosing of a Novel "Cytotopic" Anti-Thrombin Without Prolonged Anticoagulation.

Journal: Journal of the American Heart Association

Published: July 03, 2020

PAR-1 signaling on macrophages is required for effective in vivo delayed-type hypersensitivity responses.

PAR-1 signaling on macrophages is required for effective in vivo delayed-type hypersensitivity responses.

Journal: iScience

Published: July 01, 2020

Health-related quality of life and symptom burden of epithelioid hemangioendothelioma patients: a global patient-driven Facebook study in a very rare malignancy.

Health-related quality of life and symptom burden of epithelioid hemangioendothelioma patients: a global patient-driven Facebook study in a very rare malignancy.

Journal: Acta oncologica (Stockholm, Sweden)

Published: June 02, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026